Temple Syndrome: Comprehensive Clinical Study in Genetically Confirmed 60 Japanese Patients
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae883 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Tomoe Ogawa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan. Hauptthemen laut MEDLINE: Chromosome Disorders. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, National Center for Child Health and Development.
Abstract (Originalsprache)
Objective
Temple syndrome (TS14) is a rare 14q32.2-related imprinting disorder. Here we report comprehensive clinical findings in TS14.
Methods
We obtained detailed clinical findings in 60 Japanese patients with genetically confirmed TS14, using a questionnaire to attending physicians. The 60 patients consisted of 31 with maternal uniparental disomy 14 [UPD(14)mat], 22 with epimutation, 5 with deletions, and 2 with UPD(14)mat or epimutation.
Results
Small for gestational age, postnatal (∼2 years of age) short stature, and central precocious puberty (CPP) were identified in 88.3%, 87.0%, and 86.0% of patients, respectively. GH therapy was performed in 32 patients, increasing the median height SD score for height from −3.4 to −2.4, and GnRH analog therapy was performed in 32 patients, ameliorating CPP. Furthermore, the survey showed intellectual and developmental disabilities in 21.6% of patients, neurodevelopmental disorders in 21.6% of patients, obesity in 20.0% of patients, hypercholesterolemia in 26.5% of patients aged ≥6 years, diabetes mellitus in 12.8% of patients aged ≥9 years, and Silver-Russell syndrome-like and/or Prader-Will syndrome-like phenotypes in 87.7% of patients in infancy. Notably, 42.9% of patients were enrolled in special classes in childhood, whereas 98.2% of patients attended college or had jobs in adulthood. Hypercholesterolemia and diabetes mellitus were observed before the development of obesity in a substantial fraction of TS14 patients and were controlled by oral medications in most affected patients.
Conclusion
These results clarify the detailed clinical characteristics of TS14. On the basis of these findings, we propose an efficient diagnostic approach and pertinent clinical management for TS14 patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.
- Department of Advanced Pediatric Medicine, Tohoku University School of Medicine, Tokyo, 157-8535, Japan.
- Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Chuo 409-3898, Japan.
- Division of Pediatrics, Department of Homeostatic Regulation and Development, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
- Department of Medical Genetics, National Center for Child Health and Development, Tokyo 157-8535, Japan.
- Division of Endocrinology and Metabolism, National Center for Child Health and Development, Tokyo 157-8535, Japan.
ORCID-Profile: Akie Nakamura, Maki Fukami, Tsutomu Ogata, Masayo Kagami
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
- National Center for Child Health and Development
- Naito Science & Engineering Foundation
- Japanese Society for Pediatric Endocrinology Future Development
- Takeda Science Foundation
Zitieren
APA
Ogawa, T., Narusawa, H., Nagasaki, K., Kosaki, R., Naiki, Y., Aramaki, M., Matsubara, K., Nakamura, A., Fukami, M., Ogata, T., & Kagami, M. (2025). Temple Syndrome: Comprehensive Clinical Study in Genetically Confirmed 60 Japanese Patients. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae883
Vancouver
Ogawa T, Narusawa H, Nagasaki K, Kosaki R, Naiki Y, Aramaki M, et al. Temple Syndrome: Comprehensive Clinical Study in Genetically Confirmed 60 Japanese Patients. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae883
BibTeX
@article{Ogawa2025,
author = {Ogawa, Tomoe and Narusawa, Hiromune and Nagasaki, Keisuke and Kosaki, Rika and Naiki, Yasuhiro and Aramaki, Michihiko and Matsubara, Keiko and Nakamura, Akie and Fukami, Maki and Ogata, Tsutomu and Kagami, Masayo},
title = {Temple Syndrome: Comprehensive Clinical Study in Genetically Confirmed 60 Japanese Patients},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae883}
}
EUVIMED